Understanding the factors associated with willingness to participate in a COVID-19 vaccine clinical trial

Winifred Ekezie; Luis  Vaz; Barbara Czyznikowska; Carol  Akroyd; Melanie  Davies; Kamlesh Khunti

Understanding the factors associated with willingness to participate in a COVID-19 vaccine clinical trial

Winifred Ekezie
, Luis Vaz
, Barbara Czyznikowska
, Carol Akroyd
, Melanie Davies
, Kamlesh Khunti

Research output: Book/Report › Other report

7 Downloads (Pure)

Abstract

The coronavirus (COVID-19) pandemic has affected some groups more than others in the UK, and the most favourable control scenario besides face coverings, hygiene and social distancing, which could provide long-term protection, is vaccination. Development of vaccines require representation from all population groups in clinical trials, yet there have been severe under-representation among some groups, mostly ethnic minorities.

Original language	English
Number of pages	13
Publication status	Published - 1 Dec 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

Understanding the factors associated with willingness to participate in a COVID-19 vaccine clinical trialFinal published version, 386 KB

Cite this

@book{06815b6ab38d4b31b906d8ce2a0d1953,

title = "Understanding the factors associated with willingness to participate in a COVID-19 vaccine clinical trial",

abstract = "The coronavirus (COVID-19) pandemic has affected some groups more than others in the UK, and the most favourable control scenario besides face coverings, hygiene and social distancing, which could provide long-term protection, is vaccination. Development of vaccines require representation from all population groups in clinical trials, yet there have been severe under-representation among some groups, mostly ethnic minorities.",

author = "Winifred Ekezie and Luis Vaz and Barbara Czyznikowska and Carol Akroyd and Melanie Davies and Kamlesh Khunti",

year = "2020",

month = dec,

day = "1",

language = "English",

}

TY - BOOK

T1 - Understanding the factors associated with willingness to participate in a COVID-19 vaccine clinical trial

AU - Ekezie, Winifred

AU - Vaz, Luis

AU - Czyznikowska, Barbara

AU - Akroyd, Carol

AU - Davies, Melanie

AU - Khunti, Kamlesh

PY - 2020/12/1

Y1 - 2020/12/1

N2 - The coronavirus (COVID-19) pandemic has affected some groups more than others in the UK, and the most favourable control scenario besides face coverings, hygiene and social distancing, which could provide long-term protection, is vaccination. Development of vaccines require representation from all population groups in clinical trials, yet there have been severe under-representation among some groups, mostly ethnic minorities.

AB - The coronavirus (COVID-19) pandemic has affected some groups more than others in the UK, and the most favourable control scenario besides face coverings, hygiene and social distancing, which could provide long-term protection, is vaccination. Development of vaccines require representation from all population groups in clinical trials, yet there have been severe under-representation among some groups, mostly ethnic minorities.

UR - https://arc-em.nihr.ac.uk/arc-store-resources/understanding-factors-associated-willingness-participate-covid-19-vaccine

M3 - Other report

BT - Understanding the factors associated with willingness to participate in a COVID-19 vaccine clinical trial

ER -

Understanding the factors associated with willingness to participate in a COVID-19 vaccine clinical trial

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this